Delivery Order SPE2DB20D1109-SPE2DB25FN61B
Award Date
2/24/25
Potential Completion Date
2/25/25
Potential Value
$7.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,556.64, is for the delivery of MICARDIS HCT 80-25 MG TABLET UD 30S, a cardiovascular medication. The contract is a firm fixed-price delivery order with a completion date of January 18, 2024. The contract was awarded on January 17, 2024 and does not have a set-aside designation, indicating open...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of MICARDIS HCT 80-25 MG TABLET UD 30S, a cardiovascular medication, with a ceiling value of $1,353.96 and a completion date of March 5, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,375.44, is for the supply of MICARDIS HCT 80-12.5 MG TABLET UD 30S, a cardiovascular medication. The contract has a firm fixed price and an ultimate completion date of May 9, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $1,818.62 to AmerisourceBergen Drug Corp for the supply of MICARDIS HCT 80-25 MG TABLET UD 30S. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,063.60 firm fixed-price delivery order is for the supply of MICARDIS HCT 80-25 MG TABLET UD 30S, a cardiovascular medication. The award is not designated as a set-aside contract. The contract has an ultimate completion date of September 18, 2024 and is associated with a larger Indefinite Delivery Contract (IDC)...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,930.67, is for the delivery of MICARDIS HCT 80-25 MG TABLET UD 30S, a cardiovascular medication. The contract has a firm fixed price pricing type and a completion date of June 18, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $5,449.90 Firm Fixed Price delivery order is for the procurement of MICARDIS HCT 80-25 MG TABLET UD 30S, a cardiovascular medication. This contract is not set aside and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which enables the efficient procurement of a...
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MICARDIS HCT 40-12.5 MG TABLET UD 30S, a prescription medication, with an award value of $1,489.47 and a completion date of October 26, 2023. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
This is a delivery order contract awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,521.63 fixed-price contract is for the delivery of MICARDIS HCT 40-12.5 mg tablets through November 30, 2023. It is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical to provide a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, for the delivery of MICARDIS HCT 40-12.5 MG TABLET UD 30S. The contract has a ceiling value of $2,343.40 and runs through November 29, 2024. This appears to be a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. The IDC serves as the primary vehicle for providing...